{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:58:10Z","timestamp":1762091890047,"version":"build-2065373602"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00259-023-06428-5","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T10:01:42Z","timestamp":1694858502000},"page":"606-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SSTR antagonist [68Ga]Ga-DOTA-LM3 differentiates intrapancreatic accessory spleen from neuroendocrine tumor in a patient presenting indeterminate MRI and SSTR agonist [68Ga]Ga-DOTATATE"],"prefix":"10.1007","volume":"51","author":[{"given":"Weizhi","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YiZhen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-8884","authenticated-orcid":false,"given":"Haojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,16]]},"reference":[{"key":"6428_CR1","first-page":"816","volume":"19","author":"EB Bostanci","year":"2016","unstructured":"Bostanci EB, Oter V, Okten S, Kucuk NO, Soydal C, Turhan N, et al. Intra-pancreatic accessory spleen mimicking pancreatic neuroendocrine tumor on 68-Ga-dotatate PET\/CT. Arch Iran Med. 2016;19:816\u20139.","journal-title":"Arch Iran Med"},{"key":"6428_CR2","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1007\/s00259-023-06182-8","volume":"50","author":"W Guo","year":"2023","unstructured":"Guo W, Chen Y, He X, Fu H, Huang J, Chen H. [(68) Ga]Ga-DOTATATE PET\/CT versus [(68) Ga]Ga-exendin-4 PET\/CT in the evaluation of metastatic insulinoma. Eur J Nucl Med Mol Imaging. 2023;50:2910\u20131. https:\/\/doi.org\/10.1007\/s00259-023-06182-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6428_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/RLU.0000000000003895","volume":"47","author":"Y Pang","year":"2022","unstructured":"Pang Y, Meng T, Shang Q, Chen Z, Chen H. 68Ga-Exendin-4 PET\/CT differentiates insulinoma from accessory spleen in a patient presenting indeterminate MRI and 68Ga-DOTATATE PET\/CT findings. Clin Nucl Med. 2022;47:265\u20137. https:\/\/doi.org\/10.1097\/RLU.0000000000003895.","journal-title":"Clin Nucl Med"},{"key":"6428_CR4","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.2967\/jnumed.120.253096","volume":"62","author":"W Zhu","year":"2021","unstructured":"Zhu W, Cheng Y, Jia R, Zhao H, Bai C, Xu J, et al. A prospective, randomized, double-blind study to evaluate the safety, biodistribution, and dosimetry of (68)Ga-NODAGA-LM3 and (68)Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors. J Nucl Med. 2021;62:1398\u2013405. https:\/\/doi.org\/10.2967\/jnumed.120.253096.","journal-title":"J Nucl Med"},{"key":"6428_CR5","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00259-021-05512-y","volume":"49","author":"W Zhu","year":"2022","unstructured":"Zhu W, Jia R, Yang Q, Cheng Y, Zhao H, Bai C, et al. A prospective randomized, double-blind study to evaluate the diagnostic efficacy of (68)Ga-NODAGA-LM3 and (68)Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with (68)Ga-DOTATATE. Eur J Nucl Med Mol Imaging. 2022;49:1613\u201322. https:\/\/doi.org\/10.1007\/s00259-021-05512-y.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06428-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06428-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06428-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T09:02:15Z","timestamp":1704704535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06428-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,16]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6428"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06428-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"type":"print","value":"1619-7070"},{"type":"electronic","value":"1619-7089"}],"subject":[],"published":{"date-parts":[[2023,9,16]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Xiamen University, and written informed consent for publication of this report was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent and ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}